A consortium of 21 major financial institutions, including Goldman Sachs, Bank of America, and Citi, aims to launch a shared digital dollar stablecoin by early 2027. This initiative seeks to reduce reliance on Circle's USDC by giving banks greater control over stablecoin reserves, customer balances, and revenue. The shared stablecoin could solve fragmentation issues caused by individual bank tokens and target cross-border payments and digital asset settlements. However, the new digital dollar must compete with USDC's established liquidity and network effects to succeed.
The consortium of 21 major banks planning a shared digital dollar stablecoin is notable alongside Pluang's market data showing 45 of 50 major cryptocurrencies rose today. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Nov 04, 2026 22:22 WIB: THETA rose 5.68% to Rp2.885 with 96% sell orders, LINK increased 5.32% to Rp213.722 with 73% buy orders, and AVAX gained 5.26% to Rp164.500 with 62% buy orders.
The global AI accelerator market is projected to grow from $151 billion in 2025 to $443 billion by 2030, with a compound annual growth rate of about 24%. This expansion is fueled by the rise of generative AI, large language models, and increased inve...
A growing town replaced its inefficient IT request process of spreadsheets and emails with a centralized Microsoft Power Apps hub developed by eSoftware Associates. This hub integrates project intake, risk assessment, and PMO scoring into one platfor...
No7 Software has enhanced its Anchor Loyalty & Rewards app by integrating Shopify POS, allowing merchants to run a unified loyalty program across online stores and physical shops. Customers now maintain a single points balance, tier status, and refer...
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
